These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 30243011

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The association between clinically suspect arthralgia and adipokines in obese patients.
    Kose R, Sargin G, Senturk T, Cildag S, Unubol M, Abas Bİ, Yenisey C.
    Acta Reumatol Port; 2018; 43(4):284-290. PubMed ID: 30641537
    [Abstract] [Full Text] [Related]

  • 23. Chemerin is associated with inflammatory markers and metabolic syndrome phenotypes in hypertension patients.
    Gu P, Jiang W, Lu B, Shi Z.
    Clin Exp Hypertens; 2014; 36(5):326-32. PubMed ID: 24047472
    [Abstract] [Full Text] [Related]

  • 24. Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis.
    Li Y, Shi B, Li S.
    PLoS One; 2014; 9(12):e113915. PubMed ID: 25469985
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus.
    Erdmann J, Salmhofer H, Knauß A, Mayr M, Wagenpfeil S, Sypchenko O, Luppa P, Schusdziarra V.
    Regul Pept; 2012 Oct 10; 178(1-3):6-10. PubMed ID: 22387701
    [Abstract] [Full Text] [Related]

  • 28. Circulating chemerin decreases in response to a combined strength and endurance training.
    Stefanov T, Blüher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Temelkova-Kurktschiev T.
    Endocrine; 2014 Apr 10; 45(3):382-91. PubMed ID: 23783366
    [Abstract] [Full Text] [Related]

  • 29. Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines.
    Reinehr T, Karges B, Meissner T, Wiegand S, Stoffel-Wagner B, Holl RW, Woelfle J.
    J Pediatr; 2016 Jun 10; 173():131-5. PubMed ID: 26996723
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Circulating levels of the adipokine chemerin in gestational diabetes mellitus.
    Pfau D, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lössner U, Blüher M, Stumvoll M, Fasshauer M.
    Horm Res Paediatr; 2010 Jun 10; 74(1):56-61. PubMed ID: 20424419
    [Abstract] [Full Text] [Related]

  • 33. Irisin in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS.
    Metabolism; 2014 Feb 10; 63(2):207-17. PubMed ID: 24140091
    [Abstract] [Full Text] [Related]

  • 34. Does fetuin-A mediate the association between pro-inflammatory diet and type-2 diabetes mellitus risk?
    Toprak K, Görpelioğlu S, Özsoy A, Özdemir Ş, Ayaz A.
    Nutr Hosp; 2022 Mar 29; 39(2):383-392. PubMed ID: 34841880
    [Abstract] [Full Text] [Related]

  • 35. Association of chemerin levels and bone mineral density in Chinese obese postmenopausal women.
    Shi L, Mao C, Wang X, Liu R, Li L, Mou X, Xu P, Li H, Xu C, Yuan G, Wan B, Zhang H.
    Medicine (Baltimore); 2016 Aug 29; 95(35):e4583. PubMed ID: 27583869
    [Abstract] [Full Text] [Related]

  • 36. Circulating and Adipose Levels of Adipokines Associated With Insulin Sensitivity in Nonobese Subjects With Type 2 Diabetes.
    Andersson DP, Laurencikiene J, Acosta JR, Rydén M, Arner P.
    J Clin Endocrinol Metab; 2016 Oct 29; 101(10):3765-3771. PubMed ID: 27501281
    [Abstract] [Full Text] [Related]

  • 37. Chemerin as a mediator between obesity and vascular inflammation in children.
    Landgraf K, Friebe D, Ullrich T, Kratzsch J, Dittrich K, Herberth G, Adams V, Kiess W, Erbs S, Körner A.
    J Clin Endocrinol Metab; 2012 Apr 29; 97(4):E556-64. PubMed ID: 22438234
    [Abstract] [Full Text] [Related]

  • 38. Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism.
    Takahashi M, Inomata S, Okimura Y, Iguchi G, Fukuoka H, Miyake K, Koga D, Akamatsu S, Kasuga M, Takahashi Y.
    Endocr J; 2013 Apr 29; 60(1):37-44. PubMed ID: 22986456
    [Abstract] [Full Text] [Related]

  • 39. Inverse Relationship of the CMKLR1 Relative Expression and Chemerin Serum Levels in Obesity with Dysmetabolic Phenotype and Insulin Resistance.
    Corona-Meraz FI, Navarro-Hernández RE, Ruíz-Quezada SL, Madrigal-Ruíz PM, Castro-Albarrán J, Chavarría-Ávila E, Guzmán-Ornelas MO, Gómez-Bañuelos E, Petri MH, Ramírez-Cedano JI, Aguilar-Aldrete ME, Ríos-Ibarra C, Vázquez-Del Mercado M.
    Mediators Inflamm; 2016 Apr 29; 2016():3085390. PubMed ID: 27239101
    [Abstract] [Full Text] [Related]

  • 40. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease.
    Coimbra S, Brandão Proença J, Santos-Silva A, Neuparth MJ.
    Biomed Res Int; 2014 Apr 29; 2014():701915. PubMed ID: 25105135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.